# US 8,309,077 B2 · Stabilized bacteriophage formulations

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,309,077 B2
- Document ID: US8309077B2
- Status: Granted
- Kind: B2
- Application number: 11/666,709
- Filed: 2005-11-02
- Published: 2008-02-14
- Granted: 2012-11-13
- Earliest claimed: 2004-11-02
- Assignees: Chr. Hansen A/S
- Inventors: Kishore Murthy; Rainer Engelhardt
- Web page: https://patentgrep.com/patent/US8309077B2

## CPC

- A61K 35/76: Viruses; Subviral particles; Bacteriophages
- A23K 20/195: Antibiotics
- A23K 50/10: for ruminants
- A23K 50/75: for poultry
- A23K 50/80: for aquatic animals, e.g. fish, crustaceans or molluscs
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- A61P 31/04: Antibacterial agents
- C12N 2795/00032: Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
- C12N 2795/00051: Methods of production or purification of viral material
- Y02A 40/818: Alternative feeds for fish, e.g. in aquacultures
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23K: FODDER
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

Stabilized bacteriophage compositions, and methods for preparing stabilized bacteriophage compositions are provided. The method for producing an antibacterial composition involves adsorbing an aqueous solution of one or more bacteriophages, or one or more phage components, onto a matrix to produce a composition, and drying the composition to produce the antibacterial composition. An antibacterial composition comprising one or more strain of bacteriophage, or one or more phage component, adsorbed onto a matrix is also provided. The antibacterial composition, or the antibacterial composition embedded in a solid support, may be used within a cream, lotion or gel, be admixed with a pharmaceutical carrier and administered topically, orally, nasally, used as a powdered inhalant, or the antibacterial composition or encapsulated antibacterial composition, may be added to a feed for animal, aquatic or avian uses.

## Claims

### Claim 1

An antibacterial composition consisting essentially of one or more than one bacteriophage adsorbed onto a dry matrix of milk powder, wherein when the composition is stored at room temperature for up to 131 days, all bacteriophage remain viable.

### Claim 2 (depends on 1)

A composition comprising the antibacterial composition of claim 1 and a pharmaceutically acceptable carrier.

### Claim 3 (depends on 2)

A kit comprising a sterile vial comprising the composition of claim 2 and a vial of sterile water for dissolving the composition.

### Claim 4 (depends on 1)

A composition comprising an animal feed admixed with the antibacterial composition of claim 1.

### Claim 5 (depends on 4)

The composition of claim 4, wherein the animal feed is selected from the group consisting of a human food, bird feed, a fish feed, a porcine feed, a livestock feed, a poultry feed, a domestic animal feed, and a food for aquaculture.

### Claim 6 (depends on 1)

The antibacterial composition of claim 1, wherein the composition is formulated within a tablet.

### Claim 7 (depends on 6)

The antibacterial composition of claim 6, wherein the tablet further comprises components that permit controlled release of the one or more than one bacteriophage.

### Claim 8 (depends on 1)

The antibacterial composition of claim 1, wherein the antibacterial composition is embedded in a solid support.

### Claim 9 (depends on 8)

The antibacterial composition of claim 8, wherein the solid support is selected from the group consisting of a microbead, cellulose-based material, carbohydrate-based material, shellac, methacrylates, sugar, mannitol, sorbitol, soya protein, whey protein, algal protein, single cell protein, casein, gelatin, and milk powder.

### Claim 10 (depends on 1)

The antibacterial composition according to claim 1, wherein the antibacterial composition is coated with a substance that increases the resistance of the one or more than one bacteriophage to the physico-chemical stresses of the environment of a fermenting animal feed or the digestive system of an animal.

### Claim 11 (depends on 10)

The antibacterial composition according to claim 10, wherein the substance is a polymer for controlled release of the one or more than one bacteriophage.

### Claim 12 (depends on 11)

The antibacterial composition according to claim 11, wherein the polymer is a methacrylate-based polymer.
